LexaGene Holdings Inc. (CVE:LXG – Get Free Report)’s share price fell 19.2% on Thursday . The company traded as low as C$0.10 and last traded at C$0.11. 2,135,375 shares were traded during trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Stock Performance
The company has a debt-to-equity ratio of 138.01, a quick ratio of 1.13 and a current ratio of 1.39. The stock’s 50-day simple moving average is C$0.11 and its two-hundred day simple moving average is C$0.11. The stock has a market cap of C$14.77 million, a price-to-earnings ratio of -1.31 and a beta of 2.26.
About LexaGene
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
See Also
- Five stocks we like better than LexaGene
- What Makes a Stock a Good Dividend Stock?
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- Are Penny Stocks a Good Fit for Your Portfolio?
- MarketBeat Week in Review – 11/18 – 11/22
- The Risks of Owning Bonds
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
